Obesity and binge alcohol intake are deadly combination to induce steatohepatitis: A model of high-fat diet and binge ethanol intake
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Obesity and binge drinking often coexist and work synergistically to promote steatohepatitis; however, the underlying mechanisms remain obscure. In this mini-review, we briefly summarize clinical evidence of the synergistical effect of obesity and heavy drinking on steatohepatitis and discuss the underlying mechanisms obtained from the study of several mouse models. High-fat diet (HFD) feeding and binge ethanol synergistically induced steatohepatitis and fibrosis in mice with significant intrahepatic neutrophil infiltration; such HFD-plus-ethanol treatment markedly up-regulated the hepatic expression of many chemokines with the highest fold (approximately 30-fold) induction of chemokine (C-X-C motif) ligand 1 (Cxcl1), which contributes to hepatic neutrophil infiltration and liver injury. Furthermore, HFD feeding activated peroxisome proliferator-activated receptor gamma that subsequently inhibited CXCL1 upregulation in hepatocytes, thereby forming a negative feedback loop to prevent neutrophil overaction; whereas binge ethanol blocked this loop and then exacerbated CXCL1 elevation, neutrophil infiltration, and liver injury. Interestingly, inflamed mouse hepatocytes attracted neutrophils less effectively than inflamed human hepatocytes due to the lower induction of CXCL1 and the lack of the interleukin (IL)-8 gene in the mouse genome, which may be one of the reasons for difficulty in development of mouse models of alcoholic steatohepatitis and nonalcoholic steatohepatitis (NASH). Hepatic overexpression of Cxcl1 and/or IL-8 promoted steatosis-to-NASH progression in HFD-fed mice by inducing neutrophil infiltration, oxidative stress, hepatocyte death, fibrosis, and p38 mitogen-activated protein kinase activation. Collectively, obesity and binge drinking synergistically promote steatohepatitis via the induction of CXCL1 and subsequent hepatic neutrophil infiltration.
Abstract
Obesity and binge drinking often coexist and work synergistically to promote steatohepatitis; however, the underlying mechanisms remain obscure. In this mini-review, we briefly summarize clinical evidence of the synergistical effect of obesity and heavy drinking on steatohepatitis and discuss the underlying mechanisms obtained from the study of several mouse models. High-fat diet (HFD) feeding and binge ethanol synergistically induced steatohepatitis and fibrosis in mice with significant intrahepatic neutrophil infiltration; such HFD-plus-ethanol treatment markedly up-regulated the hepatic expression of many chemokines with the highest fold (approximately 30-fold) induction of chemokine (C-X-C motif) ligand 1 (Cxcl1), which contributes to hepatic neutrophil infiltration and liver injury. Furthermore, HFD feeding activated peroxisome proliferator-activated receptor gamma that subsequently inhibited CXCL1 upregulation in hepatocytes, thereby forming a negative feedback loop to prevent neutrophil overaction; whereas binge ethanol blocked this loop and then exacerbated CXCL1 elevation, neutrophil infiltration, and liver injury. Interestingly, inflamed mouse hepatocytes attracted neutrophils less effectively than inflamed human hepatocytes due to the lower induction of CXCL1 and the lack of the interleukin (IL)-8 gene in the mouse genome, which may be one of the reasons for difficulty in development of mouse models of alcoholic steatohepatitis and nonalcoholic steatohepatitis (NASH). Hepatic overexpression of Cxcl1 and/or IL-8 promoted steatosis-to-NASH progression in HFD-fed mice by inducing neutrophil infiltration, oxidative stress, hepatocyte death, fibrosis, and p38 mitogen-activated protein kinase activation. Collectively, obesity and binge drinking synergistically promote steatohepatitis via the induction of CXCL1 and subsequent hepatic neutrophil infiltration.
참고문헌 (64)
- Parker R, "Alcohol, adipose tissue and liver disease : mechanistic links and clinical considerations", Nat Rev Gastroenterol Hepatol, 15, pp.50~59 (2018)
- Parker R, "Obesity in acute alcoholic hepatitis increases morbidity and mortality", EBioMedicine, 45, pp.511~518 (2019)
- Inbeom Kwon, "Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease", Gut and Liver, 13(3), pp.308~314 (2019), 거트앤리버 소화기연관학회협의회[DOI]
- Ajmera VH, "Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review", Hepatology, 65, pp.2090~2099 (2017)
- Xu J, "Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK", J Hepatol, 55, pp.673~682 (2011)
- Chang B, "Short-or longterm high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice : an important role for CXCL1", Hepatology, 62, pp.1070~1085 (2015)
- Zhou Z, "Neutrophilhepatic stellate cell interactions promote fibrosis in experimental steatohepatitis", Cell Mol Gastroenterol Hepatol, 5, pp.399~413 (2018)
- Åberg F, "Risks of light and moderate alcohol use in fatty liver disease : follow-up of population cohorts", Hepatology, 71, pp.835~848 (2020)
- Alatalo PI, "Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index", Am J Clin Nutr, 88, pp.1097~1103 (2008)
- Chang Y, "Nonheavy drinking and worsening of noninvasive fibrosis markers in nonalcoholic fatty liver disease : a cohort study", Hepatology, 69, pp.64~75 (2019)
- Gow P, "Letter to the editor : moderate alcohol use in fatty liver disease : don’t throw the cabernet out with the bathwater", Hepatology, 71, pp.1887~1888 (2020)
- Loomba R, "Clinical trial : pilot study of metformin for the treatment of nonalcoholic steatohepatitis", Aliment Pharmacol Ther, 29, pp.172~182 (2009)
- Shen Z, "A cohort study of the effect of alcohol consumption and obesity on serum liver enzyme levels", Eur J Gastroenterol Hepatol, 22, pp.820~825 (2010)
- Wong VW, "Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese : a population study using protonmagnetic resonance spectroscopy and transient elastography", Gut, 61, pp.409~415 (2012)
- Moriya A, "Roles of alcohol consumption in fatty liver : a longitudinal study", J Hepatol, 62, pp.921~927 (2015)
- Dunn W, "Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease", Hepatology, 47, pp.1947~1954 (2008)
- Sookoian S, "Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease : a meta-analysis of 43 175 individuals", Gut, 63, pp.530~532 (2014)
- Chang Y, "Low levels of alcohol consumption, obesity, and development of fatty liver with and without evidence of advanced fibrosis", Hepatology, 71, pp.861~873 (2020)
- Ajmera V, "Among patients with nonalcoholic fatty liver disease, modest alcohol use is associated with less improvement in histologic steatosis and steatohepatitis", Clin Gastroenterol Hepatol, 16, pp.1511~1520. e5 (2018)
- Vilar-Gomez E, "Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease : a multi-national cohort study", Gastroenterology, 155, pp.443~457.e17 (2018)
- Hajifathalian K, "Effect of alcohol consumption on survival in nonalcoholic fatty liver disease : a national prospective cohort study", Hepatology, 70, pp.511~521 (2019)
- VanWagner LB, "Alcohol use and cardiovascular disease risk in patients with nonalcoholic fatty liver disease", Gastroenterology, 153, pp.1260~1272. e3 (2017)
- Wood AM, "Risk thresholds for alcohol consumption : combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies", Lancet, 391, pp.1513~1523 (2018)
- Gao B, "Inflammatory pathways in alcoholic steatohepatitis", J Hepatol, 70, pp.249~259 (2019)
- Kolaczkowska E, "Neutrophil recruitment and function in health and inflammation", Nat Rev Immunol, 13, pp.159~175 (2013)
- Dominguez M, "Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis", Gastroenterology, 136, pp.1639~1650 (2009)
- Nischalke HD, "Influence of the CXCL1 rs4074 A allele on alcohol induced cirrhosis and HCC in patients of European descent", PLoS One, 8, pp.e80848~ (2013)
- Gross B, "PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD", Nat Rev Endocrinol, 13, pp.36~49 (2017)
- Xu MJ, "Fatspecific protein 27", CIDEC promotes development of alcoholic steatohepatitis in mice and humans, 2015, pp.149, 1030~1041.e6
- Zhang W, "Hepatic peroxisome proliferator-activated receptor gamma signaling contributes to alcoholinduced hepatic steatosis and inflammation in mice", Alcohol Clin Exp Res, 40, pp.988~999 (2016)
- Torres-Hernandez A, "γδ T cells promote steatohepatitis by orchestrating innate and adaptive immune programming", Hepatology, 71, pp.477~494 (2020)
- Wang X, "γδT Cells and CD1d, novel immune players in alcoholic and nonalcoholic steatohepatitis?", Hepatology, 71, pp.408~410 (2020)
- Xu D, "A hepatocyte-mimicking antidote for alcohol intoxication", Adv Mater, 30, pp.e1707443~ (2018)
- Jaeschke H, "Neutrophil-mediated tissue injury in alcoholic hepatitis", Alcohol, 27, pp.23~27 (2002)
- Bertola A, "Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice : a critical role for E-selectin", Hepatology, 58, pp.1814~1823 (2013)
- Koyama Y, "Liver inflammation and fibrosis", J Clin Invest, 127, pp.55~64 (2017)
- Bataller R, "Liver fibrosis in alcoholic liver disease", Semin Liver Dis, 35, pp.146~156 (2015)
- Bedard K, "The NOX family of ROS-generating NADPH oxidases : physiology and pathophysiology", Physiol Rev, 87, pp.245~313 (2007)
- Lopez AF, "Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival", J Clin Invest, 78, pp.1220~1228 (1986)
- Girard D, "Differential effects of interleukin-15(IL-15)and IL-2 on human neutrophils : modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15", Blood, 88, pp.3176~3184 (1996)
- Matsumoto M, "An improved mouse model that rapidly develops fibrosis in nonalcoholic steatohepatitis", Int J Exp Pathol, 94, pp.93~103 (2013)
- Hwang S, "How does your fat affect your liver when you drink?", J Clin Invest, 129, pp.2181~2183 (2019)
- Sebastian BM, "Identification of a cytochrome P4502E1", Bid, J Biol Chem, pp.2011, 286[DOI]
- Kim SJ, "Adipocyte death preferentially induces liver injury and inflammation through the activation of chemokine(C-C Motif)receptor 2-positive macrophages and lipolysis", Hepatology, 69, pp.1965~1982 (2019)
- Rinella ME, "Report on the AASLD", EASL Joint Workshop on clinical trial endpoints in NAFLD, 2019, pp.70, 1424~1436
- Sanyal AJ, "Past, present and future perspectives in nonalcoholic fatty liver disease", Nat Rev Gastroenterol Hepatol, 16, pp.377~386 (2019)
- Tilg H, "Evolution of inflammation in nonalcoholic fatty liver disease : the multiple parallel hits hypothesis", Hepatology, 52, pp.1836~1846 (2010)
- Gao B, "Inflammation in alcoholic and nonalcoholic fatty liver disease : friend or foe?", Gastroenterology, 150, pp.1704~1709 (2016)
- Bertola A, "Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients", PLoS One, 5, pp.e13577~ (2010)
- Hwang S, "Interleukin-22ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets", Hepatology, 72, pp.412~429 (2020)
- Hwang S, "Protective and detrimental roles of p38α MAPK in different stages of nonalcoholic fatty liver disease", Hepatology (2020)[DOI]
- Ji C, "New Insights into the pathogenesis of alcohol-induced ER stress and liver diseases", Int J Hepatol, 2014, pp.513787~ (2014)
- Wang S, "A mechanistic review of cell death in alcohol-induced liver injury", Alcohol Clin Exp Res, 40, pp.1215~1223 (2016)
- Farrell G, "Mouse models of nonalcoholic steatohepatitis : toward optimization of their relevance to human nonalcoholic steatohepatitis", Hepatology, 69, pp.2241~2257 (2019)
- Tsuchida T, "A simple diet-and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer", J Hepatol, 69, pp.385~395 (2018)
- von Vietinghoff S, "Homeostatic regulation of blood neutrophil counts", J Immunol, 181, pp.5183~5188 (2008)
- Sinclair J, "Hepatic alcohol dehydrogenase activity in chick hepatocytes towards the major alcohols present in commercial alcoholic beverages : comparison with activities in rat and human liver", Comp Biochem Physiol B, 96, pp.677~682 (1990)
- Hart CL, "Effect of body mass index and alcohol consumption on liver disease : analysis of data from two prospective cohort studies", BMJ, 340, pp.c1240~ (2010)
- Everitt H, "Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice", Am J Physiol Gastrointest Liver Physiol, 304, pp.G38~G47 (2013)
- Minato T, "Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-induced simple steatosis", Mol Med, 20, pp.490~502 (2014)
- Alwahsh SM, "Combination of alcohol and fructose exacerbates metabolic imbalance in terms of hepatic damage, dyslipidemia, and insulin resistance in rats", PLoS One, 9, pp.e104220~ (2014)
- Duly AM, "Effect of multiple binge alcohol on diet-induced liver injury in a mouse model of obesity", Nutr Diabetes, 5, pp.e154~ (2015)
- Song M, "Chronic alcohol consumption causes liver injury in high-fructose-fed male mice through enhanced hepatic inflammatory response", Alcohol Clin Exp Res, 40, pp.518~528 (2016)
- Warner DR, "Dietary linoleic acid and its oxidized metabolites exacerbate liver injury caused by ethanol via induction of hepatic proinflammatory response in mice", Am J Pathol, 187, pp.2232~2245 (2017)